Sasiwan Kerdphoo Selected Research

Sasiwan Kerdphoo Research Topics

Disease

20	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 12/2016
14	Insulin Resistance 06/2021 - 03/2011
12	Inflammation (Inflammations) 10/2023 - 10/2017
10	Left Ventricular Dysfunction 10/2023 - 01/2018
10	Ischemia 01/2022 - 12/2016
10	Cognitive Dysfunction 01/2022 - 01/2016
9	Reperfusion Injury 10/2023 - 12/2016
9	Infarction (Infarctions) 10/2023 - 01/2018
8	Obesity 10/2023 - 01/2018
5	Cardiotoxicity 09/2023 - 10/2021
5	Cardiac Arrhythmias (Arrythmia) 01/2023 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
4	Body Weight (Weight, Body) 01/2022 - 08/2017
3	Dyslipidemias (Dyslipidemia) 04/2024 - 11/2019
3	Neoplasms (Cancer) 09/2023 - 01/2021
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2017
3	Hyperglycemia 01/2020 - 08/2017
2	Prediabetic State (Prediabetes) 10/2023 - 01/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2023 - 01/2019
2	Chemotherapy-Related Cognitive Impairment 03/2023 - 01/2021
2	Neuroinflammatory Diseases 01/2022 - 01/2021
2	Myocardial Infarction 01/2021 - 01/2019
2	Weight Gain 10/2020 - 10/2017
2	Pain (Aches) 08/2019 - 04/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2018
1	Hypertension (High Blood Pressure) 04/2024
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023
1	Tics (Tic) 09/2023
1	Heart Diseases (Heart Disease) 09/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Odontogenic Cysts (Keratocyst) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Hypertriglyceridemia 10/2020
1	Hyperlipidemias (Hyperlipidemia) 10/2020
1	Myalgia 01/2020
1	Heart Failure 01/2020
1	Weight Loss (Weight Reduction) 11/2019
1	Fibromyalgia (Fibrositis) 08/2019

Drug/Important Bio-Agent (IBA)

15	Insulin (Novolin)FDA Link 01/2022 - 03/2011
12	Proteins (Proteins, Gene)FDA Link 10/2023 - 03/2017
7	Metformin (Glucophage)FDA LinkGeneric 02/2023 - 10/2020
5	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 10/2023 - 01/2018
5	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2023 - 01/2021
5	LipidsIBA 01/2022 - 09/2018
5	Atorvastatin (Lipitor)FDA Link 10/2020 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 12/2016
4	Donepezil (Aricept)FDA LinkGeneric 03/2023 - 01/2021
4	MelatoninIBA 02/2023 - 01/2021
4	salicylhydroxamic acid (SHAM)IBA 10/2020 - 01/2019
3	Amyloid beta-PeptidesIBA 01/2021 - 07/2017
3	Estrogens (Estrogen)FDA Link 01/2019 - 07/2017
3	VildagliptinIBA 01/2019 - 10/2017
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 07/2017
2	Trastuzumab (Herceptin)FDA Link 09/2023 - 01/2023
2	CholesterolIBA 06/2021 - 11/2019
2	Galactose (Galactopyranose)FDA LinkGeneric 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 09/2018
2	Proprotein Convertase 9IBA 10/2020 - 01/2020
2	dapagliflozinIBA 01/2020 - 10/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2019
2	CytokinesIBA 01/2020 - 04/2018
2	coenzyme Q10 (CoQ10)IBA 08/2019 - 04/2018
2	AntioxidantsIBA 08/2019 - 04/2018
2	Testosterone (Sustanon)FDA Link 01/2019 - 01/2018
2	fibroblast growth factor 21IBA 01/2018 - 01/2016
1	CreatinineIBA 04/2024
1	Dynamins (Dynamin)IBA 10/2023
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2023
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2023
1	human ERBB2 proteinIBA 09/2023
1	Cholinergic ReceptorsIBA 09/2023
1	A-factor (Streptomyces)IBA 01/2023
1	Dacarbazine (DIC)FDA LinkGeneric 12/2022
1	Toll-Like Receptor 4IBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Therapeutic UsesIBA 06/2021
1	oxidized low density lipoproteinIBA 06/2021
1	psicose (D-psicose)IBA 06/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	EsterasesIBA 01/2021
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2021
1	necrostatin-1IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	Protons (Proton)IBA 12/2020
1	Malondialdehyde (Propanedial)IBA 10/2020
1	AMP-Activated Protein KinasesIBA 10/2020
1	SodiumIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	Advanced Glycation End ProductsIBA 01/2020
1	SymportersIBA 01/2020
1	Amyloidogenic ProteinsIBA 01/2020

Therapy/Procedure

9	Therapeutics 10/2023 - 10/2017
2	Drug Therapy (Chemotherapy) 01/2021 - 10/2017
1	Vagus Nerve Stimulation 12/2022
1	Hyperbaric Oxygenation 01/2021
1	Intravenous Injections 01/2021